These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37061331)

  • 1. Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis.
    Rezaeian AH; Inuzuka H; Wei W
    Adv Protein Chem Struct Biol; 2023; 135():179-201. PubMed ID: 37061331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
    Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
    Nature; 2018 Jan; 553(7686):91-95. PubMed ID: 29160310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D.
    Chaikovsky AC; Li C; Jeng EE; Loebell S; Lee MC; Murray CW; Cheng R; Demeter J; Swaney DL; Chen SH; Newton BW; Johnson JR; Drainas AP; Shue YT; Seoane JA; Srinivasan P; He A; Yoshida A; Hipkins SQ; McCrea E; Poltorack CD; Krogan NJ; Diehl JA; Kong C; Jackson PK; Curtis C; Petrov DA; Bassik MC; Winslow MM; Sage J
    Nature; 2021 Apr; 592(7856):794-798. PubMed ID: 33854239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRL4
    Simoneschi D; Rona G; Zhou N; Jeong YT; Jiang S; Milletti G; Arbini AA; O'Sullivan A; Wang AA; Nithikasem S; Keegan S; Siu Y; Cianfanelli V; Maiani E; Nazio F; Cecconi F; Boccalatte F; Fenyö D; Jones DR; Busino L; Pagano M
    Nature; 2021 Apr; 592(7856):789-793. PubMed ID: 33854235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D-CDK4/6 functions in cancer.
    Gao X; Leone GW; Wang H
    Adv Cancer Res; 2020; 148():147-169. PubMed ID: 32723562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
    Lin Z; Zhang X; Zhao F; Ru S
    Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
    Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
    J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.
    Maiani E; Milletti G; Nazio F; Holdgaard SG; Bartkova J; Rizza S; Cianfanelli V; Lorente M; Simoneschi D; Di Marco M; D'Acunzo P; Di Leo L; Rasmussen R; Montagna C; Raciti M; De Stefanis C; Gabicagogeascoa E; Rona G; Salvador N; Pupo E; Merchut-Maya JM; Daniel CJ; Carinci M; Cesarini V; O'sullivan A; Jeong YT; Bordi M; Russo F; Campello S; Gallo A; Filomeni G; Lanzetti L; Sears RC; Hamerlik P; Bartolazzi A; Hynds RE; Pearce DR; Swanton C; Pagano M; Velasco G; Papaleo E; De Zio D; Maya-Mendoza A; Locatelli F; Bartek J; Cecconi F
    Nature; 2021 Apr; 592(7856):799-803. PubMed ID: 33854232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment.
    VanArsdale T; Boshoff C; Arndt KT; Abraham RT
    Clin Cancer Res; 2015 Jul; 21(13):2905-10. PubMed ID: 25941111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6.
    Fry DW; Bedford DC; Harvey PH; Fritsch A; Keller PR; Wu Z; Dobrusin E; Leopold WR; Fattaey A; Garrett MD
    J Biol Chem; 2001 May; 276(20):16617-23. PubMed ID: 11278443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CDK4 and CDK6: From Discovery to Therapy.
    Sherr CJ; Beach D; Shapiro GI
    Cancer Discov; 2016 Apr; 6(4):353-67. PubMed ID: 26658964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
    Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J
    Hybridoma; 1999 Jun; 18(3):225-34. PubMed ID: 10475236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells.
    The I; Ruijtenberg S; Bouchet BP; Cristobal A; Prinsen MB; van Mourik T; Koreth J; Xu H; Heck AJ; Akhmanova A; Cuppen E; Boxem M; Muñoz J; van den Heuvel S
    Nat Commun; 2015 Jan; 6():5906. PubMed ID: 25562820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.